Sanuwave Health to Uplist to the Nasdaq Global Market
Rhea-AI Summary
Sanuwave Health (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, has announced its approval for listing on the Nasdaq Global Market. The company's common stock will begin trading on Nasdaq on March 7, 2025, maintaining its current ticker symbol 'SNWV'.
The transition from OTCQB to Nasdaq represents a significant milestone for Sanuwave after 18 months of transition and progress. Stockholders are not required to take any action regarding the uplisting. CEO Morgan Frank expressed enthusiasm about joining one of the world's premier stock exchanges, highlighting the company's goal of transforming the wound care market and creating shareholder value.
Positive
- Uplisting from OTCQB to Nasdaq Global Market
- Enhanced visibility and potential trading liquidity through Nasdaq listing
- No dilutive action required from shareholders for uplisting
Negative
- None.
Trading Under the Ticker “SNWV” Expected to Begin on March 7, 2025
EDEN PRAIRIE, Minn., March 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the “Company” or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, announced today that its common stock has been approved for listing on the Nasdaq Global Market (“Nasdaq”).
Trading on Nasdaq is expected to commence at the market open on March 7, 2025, with shares continuing to trade under the ticker symbol “SNWV.” The Company’s shares will trade on the OTCQB until trading on Nasdaq commences. Stockholders are not required to take any action as a result of the uplisting.
Commenting on the announcement, CEO Morgan Frank stated, “The last 18 months have been a time of transition and progress at Sanuwave, and it’s with great excitement and pride that we join the Nasdaq Global Market, one of the premier stock exchanges in the world, as the next step toward achieving our aim of transforming the wound care market and driving value for our shareholders. This is going to be fun.”
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave’s end-to-end wound care portfolio of regenerative medicine products and product candidates helps restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to the timing of the planned uplisting to Nasdaq, future financial results, production expectations, and plans for future business development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition, and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact: investors@sanuwave.com
FAQ
When will Sanuwave Health (SNWV) start trading on the Nasdaq Global Market?
What actions do Sanuwave Health (SNWV) shareholders need to take for the Nasdaq uplisting?
What is Sanuwave Health's (SNWV) current trading market before the Nasdaq uplisting?
Will Sanuwave Health (SNWV) change its ticker symbol when listing on Nasdaq?
